Renaming will unite the medical technology and pharmaceutical segments under the Johnson & Johnson brand, help drive innovation, leverage synergies and deliver better healthcare solutions globally.
Johannesburg, December 5th, 2024 – Johnson & Johnson today announced it is updating its brand and uniting its two business segments under the Johnson & Johnson brand name in South Africa.
The announcement marks the next step in Johnson & Johnson’s South African journey. Under a single umbrella, the company plans to further leverage its expertise in innovative medicine and medical technology to treat complex diseases and introduce solutions that deliver smarter, less invasive and more personalized patient care.
Moving forward, the Company’s two segments will be more connected to the Johnson & Johnson brand. Janssen, the Company’s pharmaceutical segment, will henceforth be known as Johnson & Johnson Innovative Medicine. The medical technology segment will continue to be known as Johnson & Johnson MedTech. The changes form part of a global rollout of the new Johnson & Johnson brand, first announced in September 2023.
Ahmed El Hofy, General Manager at Johnson & Johnson Innovative Medicine South Africa said: “We are excited to enter a new era of healthcare innovation and tackling the toughest health challenges. Though our name has changed, our purpose remains the same. We will continue to focus on developing innovative treatments and championing patients every step of the way, while staying true to Our Credo values. We remain committed to serving patients, healthcare providers, and communities in South Africa and beyond.”
Johnson & Johnson Innovative Medicine applies rigorous science with compassion to confidently address the most complex diseases in the areas of Oncology, Immunology, Neuroscience, and Pulmonary Hypertension. The intent is to develop the potential medicines of tomorrow. The pharmaceuticals segment is leading where medicine is going, developing breakthrough treatments to transform the future of health.
The new Johnson & Johnson brand identity builds on the Company’s legacy, while also modernising key elements to showcase healthcare innovation in a way that’s inclusive and brings the Company’s warm, caring nature to life.
-ENDS-
ABOUT JOHNSON & JOHNSON
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.